Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Jul;151(1):281–291.

Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization.

N Okamoto 1, T Tobe 1, S F Hackett 1, H Ozaki 1, M A Vinores 1, W LaRochelle 1, D J Zack 1, P A Campochiaro 1
PMCID: PMC1857935  PMID: 9212753

Abstract

Vascular endothelial growth factor (VEGF) has been implicated in retinal neovascularization (NV), but it has been difficult to produce retinal NV with exogenous VEGF. We investigated the effect of increased VEGF expression in the retina using tissue-specific, gain-of-function transgenic mice in which the bovine rhodopsin promoter is coupled to the gene for human VEGF. Three founder mice were obtained and used to generate transgenic lines. One of the lines shows increased expression of VEGF in the retina by reverse transcription coupled to polymerase chain reaction and Northern blots, and the VEGF is localized to photoreceptors by immunohistochemistry. These mice demonstrate new vessels originating from the deep capillary bed of the retina that extend beneath the photoreceptor layer into the subretinal space where they form clumps of blood vessels surrounded by proliferated retinal pigmented epithelial cells. The appearance is similar to subretinal NV seen in some patients, except that the blood vessels originate from the retinal vasculature rather than the choroidal vasculature. One of the other two lines of mice did not show increased expression of VEGF and did not have NV; the other line showed retinal degeneration. This study demonstrates that over-expression of VEGF in the retina is sufficient to cause intraretinal and subretinal NV and provides a valuable new animal model.

Full text

PDF
281

Images in this article

284Figure 2
on p.284
284Figure 3
on p.284
285Figure 4
on p.285
286Figure 5
on p.286
287Figure 6
on p.287
288Figure 7
on p.288
288Figure 8
on p.288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHTON N. Retinal vascularization in health and disease: Proctor Award Lecture of the Association for Research in Ophthalmology. Am J Ophthalmol. 1957 Oct;44(4 Pt 2):7–17. doi: 10.1016/0002-9394(57)90426-9. [DOI] [PubMed] [Google Scholar]
  2. Adamis A. P., Miller J. W., Bernal M. T., D'Amico D. J., Folkman J., Yeo T. K., Yeo K. T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994 Oct 15;118(4):445–450. doi: 10.1016/s0002-9394(14)75794-0. [DOI] [PubMed] [Google Scholar]
  3. Adamis A. P., Shima D. T., Tolentino M. J., Gragoudas E. S., Ferrara N., Folkman J., D'Amore P. A., Miller J. W. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996 Jan;114(1):66–71. doi: 10.1001/archopht.1996.01100130062010. [DOI] [PubMed] [Google Scholar]
  4. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994 Dec 1;331(22):1480–1487. doi: 10.1056/NEJM199412013312203. [DOI] [PubMed] [Google Scholar]
  5. Aiello L. P., Pierce E. A., Foley E. D., Takagi H., Chen H., Riddle L., Ferrara N., King G. L., Smith L. E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10457–10461. doi: 10.1073/pnas.92.23.10457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Antoszyk A. N., Gottlieb J. L., Machemer R., Hatchell D. L. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol. 1993;231(1):34–40. doi: 10.1007/BF01681698. [DOI] [PubMed] [Google Scholar]
  7. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development. 1992 Feb;114(2):521–532. doi: 10.1242/dev.114.2.521. [DOI] [PubMed] [Google Scholar]
  8. Brogi E., Schatteman G., Wu T., Kim E. A., Varticovski L., Keyt B., Isner J. M. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest. 1996 Jan 15;97(2):469–476. doi: 10.1172/JCI118437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Campochiaro P. A., Chang M., Ohsato M., Vinores S. A., Nie Z., Hjelmeland L., Mansukhani A., Basilico C., Zack D. J. Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor. J Neurosci. 1996 Mar 1;16(5):1679–1688. doi: 10.1523/JNEUROSCI.16-05-01679.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Campochiaro P. A., Hackett S. F., Vinores S. A., Freund J., Csaky C., LaRochelle W., Henderer J., Johnson M., Rodriguez I. R., Friedman Z. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci. 1994 Sep;107(Pt 9):2459–2469. doi: 10.1242/jcs.107.9.2459. [DOI] [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Connolly D. T., Heuvelman D. M., Nelson R., Olander J. V., Eppley B. L., Delfino J. J., Siegel N. R., Leimgruber R. M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989 Nov;84(5):1470–1478. doi: 10.1172/JCI114322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dellian M., Witwer B. P., Salehi H. A., Yuan F., Jain R. K. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol. 1996 Jul;149(1):59–71. [PMC free article] [PubMed] [Google Scholar]
  14. Finkelstein D., Brem S., Patz A., Folkman J., Miller S., Ho-Chen C. Experimental retinal neovascularization induced by intravitreal tumors. Am J Ophthalmol. 1977 May;83(5):660–664. doi: 10.1016/0002-9394(77)90132-5. [DOI] [PubMed] [Google Scholar]
  15. Flamme I., von Reutern M., Drexler H. C., Syed-Ali S., Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev Biol. 1995 Oct;171(2):399–414. doi: 10.1006/dbio.1995.1291. [DOI] [PubMed] [Google Scholar]
  16. Frank R. N., Turczyn T. J., Das A. Pericyte coverage of retinal and cerebral capillaries. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):999–1007. [PubMed] [Google Scholar]
  17. Janzer R. C., Raff M. C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature. 1987 Jan 15;325(6101):253–257. doi: 10.1038/325253a0. [DOI] [PubMed] [Google Scholar]
  18. Kahn H. A., Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974 Jul;78(1):58–67. doi: 10.1016/0002-9394(74)90010-5. [DOI] [PubMed] [Google Scholar]
  19. Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989 Dec 8;246(4935):1306–1309. doi: 10.1126/science.2479986. [DOI] [PubMed] [Google Scholar]
  20. Lutty G. A., McLeod D. S., Merges C., Diggs A., Plouét J. Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol. 1996 Aug;114(8):971–977. doi: 10.1001/archopht.1996.01100140179011. [DOI] [PubMed] [Google Scholar]
  21. Malecaze F., Clamens S., Simorre-Pinatel V., Mathis A., Chollet P., Favard C., Bayard F., Plouet J. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol. 1994 Nov;112(11):1476–1482. doi: 10.1001/archopht.1994.01090230090028. [DOI] [PubMed] [Google Scholar]
  22. Miller H., Miller B., Ryan S. J. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci. 1986 Nov;27(11):1644–1652. [PubMed] [Google Scholar]
  23. Miller J. W., Adamis A. P., Shima D. T., D'Amore P. A., Moulton R. S., O'Reilly M. S., Folkman J., Dvorak H. F., Brown L. F., Berse B. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol. 1994 Sep;145(3):574–584. [PMC free article] [PubMed] [Google Scholar]
  24. Miller J. W., Stinson W. G., Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993 Jan;100(1):9–14. doi: 10.1016/s0161-6420(93)31712-4. [DOI] [PubMed] [Google Scholar]
  25. Murata T., Ishibashi T., Inomata H. Experimental rat model of neovascularization arising from the optic disk. Ophthalmic Res. 1993;25(3):157–161. doi: 10.1159/000267284. [DOI] [PubMed] [Google Scholar]
  26. Orlidge A., D'Amore P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol. 1987 Sep;105(3):1455–1462. doi: 10.1083/jcb.105.3.1455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ozaki H., Hayashi H., Vinores S. A., Moromizato Y., Campochiaro P. A., Oshima K. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res. 1997 Apr;64(4):505–517. doi: 10.1006/exer.1996.0239. [DOI] [PubMed] [Google Scholar]
  28. Patz A. Current concepts of the effect of oxygen on the developing retina. Curr Eye Res. 1984 Jan;3(1):159–163. doi: 10.3109/02713688408997197. [DOI] [PubMed] [Google Scholar]
  29. Pe'er J., Shweiki D., Itin A., Hemo I., Gnessin H., Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995 Jun;72(6):638–645. [PubMed] [Google Scholar]
  30. Penn J. S., Tolman B. L., Lowery L. A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993 Mar;34(3):576–585. [PubMed] [Google Scholar]
  31. Pierce E. A., Avery R. L., Foley E. D., Aiello L. P., Smith L. E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):905–909. doi: 10.1073/pnas.92.3.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992 Oct 29;359(6398):845–848. doi: 10.1038/359845a0. [DOI] [PubMed] [Google Scholar]
  33. Pournaras C. J., Tsacopoulos M., Strommer K., Gilodi N., Leuenberger P. M. Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology. 1990 Oct;97(10):1321–1328. doi: 10.1016/s0161-6420(90)32415-6. [DOI] [PubMed] [Google Scholar]
  34. Robinson G. S., Pierce E. A., Rook S. L., Foley E., Webb R., Smith L. E. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci U S A. 1996 May 14;93(10):4851–4856. doi: 10.1073/pnas.93.10.4851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  36. Smith L. E., Wesolowski E., McLellan A., Kostyk S. K., D'Amato R., Sullivan R., D'Amore P. A. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994 Jan;35(1):101–111. [PubMed] [Google Scholar]
  37. Stone J., Chan-Ling T., Pe'er J., Itin A., Gnessin H., Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1996 Feb;37(2):290–299. [PubMed] [Google Scholar]
  38. Takeshita S., Tsurumi Y., Couffinahl T., Asahara T., Bauters C., Symes J., Ferrara N., Isner J. M. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 1996 Oct;75(4):487–501. [PubMed] [Google Scholar]
  39. Tano Y., Chandler D. B., Machemer R. Retinal neovascularization after intravitreal fibroblast injection. Am J Ophthalmol. 1981 Jul;92(1):103–109. doi: 10.1016/s0002-9394(14)75913-6. [DOI] [PubMed] [Google Scholar]
  40. Tobe T., Takahashi K., Ohkuma H., Uyama M. [Experimental choroidal neovascularization in the rat]. Nippon Ganka Gakkai Zasshi. 1994 Sep;98(9):837–845. [PubMed] [Google Scholar]
  41. Tolentino M. J., Miller J. W., Gragoudas E. S., Chatzistefanou K., Ferrara N., Adamis A. P. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. Arch Ophthalmol. 1996 Aug;114(8):964–970. doi: 10.1001/archopht.1996.01100140172010. [DOI] [PubMed] [Google Scholar]
  42. Tolentino M. J., Miller J. W., Gragoudas E. S., Jakobiec F. A., Flynn E., Chatzistefanou K., Ferrara N., Adamis A. P. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology. 1996 Nov;103(11):1820–1828. doi: 10.1016/s0161-6420(96)30420-x. [DOI] [PubMed] [Google Scholar]
  43. Virdi P. S., Hayreh S. S. Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion. Arch Ophthalmol. 1982 Feb;100(2):331–341. doi: 10.1001/archopht.1982.01030030333024. [DOI] [PubMed] [Google Scholar]
  44. Wen R., Song Y., Cheng T., Matthes M. T., Yasumura D., LaVail M. M., Steinberg R. H. Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J Neurosci. 1995 Nov;15(11):7377–7385. doi: 10.1523/JNEUROSCI.15-11-07377.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zack D. J., Bennett J., Wang Y., Davenport C., Klaunberg B., Gearhart J., Nathans J. Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas. Neuron. 1991 Feb;6(2):187–199. doi: 10.1016/0896-6273(91)90355-4. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES